Premier Biomedical, Inc. (BIEI)
OTCMKTS
· Delayed Price · Currency is USD
0.0010
0.00 (0.00%)
Oct 30, 2024, 4:00 PM EDT
Premier Biomedical Revenue
In the year 2019, Premier Biomedical had annual revenue of $14.28K, down -64.11%. Premier Biomedical had revenue of $1.31K in the quarter ending December 31, 2019, a decrease of -85.63%.
Revenue
14.28K
Revenue Growth
-64.11%
P/S Ratio
3.31
Revenue / Employee
3.57K
Employees
4
Market Cap
988.99K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Ryman Healthcare Limited | 411.39M |
| Verano Holdings Corp. | 920.97M |
| Vireo Growth Inc. | 98.04M |
| Medexus Pharmaceuticals Inc. | 108.78M |
Premier Biomedical News
- 2 months ago - Premier Graphene's Proprietary Graphene-Modified Asphalt Demonstrates Substantial Stability and Performance Improvements Compared to Conventional Asphalt in Laboratory Tests - GlobeNewsWire
- 4 months ago - Premier Graphene, Inc. Ships Advanced Graphene Suspension Samples to Global Leader in Essential Materials - GlobeNewsWire
- 2 years ago - Premier Biomedical Inc. (OTC PINK: BIEI), now known as Nova-Graphene Ballistics, Inc., Announces Agreements to Manufacture its Revolutionary 3D-Printed Ballistic Armor Using its Proprietary Graphene Production Methodology - GlobeNewsWire